H. Lundbeck A/S
Solid performance in the first quarter of the year. Full year guidance maintained

DGAP-News: H. Lundbeck A/S

2015-05-06 / 08:06

---------------------------------------------------------------------

Valby, Denmark, 2015-05-06 08:06 CEST (GLOBE NEWSWIRE) -- HIGHLIGHTS

  -- Kåre Schultz appointed as new president and CEO. He will join Lundbeck on
     20 May 2015 (see separate release)
  -- Core revenue remained stable compared to last year as the expected
     genericization of both Cipralex and Ebixa sales are off-set by appreciation
     of key currencies and growth in other products. Core EBIT margin reached 6%
     in spite of significant launch costs
  -- The launch program of the strategic core products Abilify Maintena(R),
     Brintellix(R), Northera(R) and Selincro(R) continued in the first quarter of 2015
     with more than 20 individual country launches
  -- Revenue from strategic core products grew by 229% to DKK 691 million in the
     first quarter representing close to 20% of total revenue
  -- US revenue growth continued and reached DKK 1,335 million, an increase of
     50% in local currency, representing 38% of Lundbeck's revenue
  -- Revenue in International Markets was stable at DKK 1,151 million as generic
     erosion of Cipralex was mitigated by strong growth of other products and
     product launches, representing 32% of revenue
  -- Brintellix sales reached DKK 98 million, with non-US markets contributing
     DKK 24 million. Outside the US, Brintellix has now been launched in more
     than 20 countries and sales uptake is in line with expectations
  -- Abilify Maintena launches continue as planned and the product reached DKK
     120 million in the quarter - up more than 300%
  -- Onfi continues its solid performance growing 130% in the quarter to DKK 390
     million
  -- Selincro continues to perform in markets with full market access such as
     France
  -- Financial guidance for 2015 is maintained at DKK 13.2-13.7 billion in core
     revenue and around DKK 0 in core EBIT



In connection with the financial report, Lundbeck's Chairman, Håkan Björklund
said: 

'I am pleased to see our portfolio of core products showing good performance
and now represent some 20% of revenue. In the quarter we have made more than 20
launches on top of the 39 made last year and we will see further acceleration
with launches in several new markets throughout 2015'. 



DKK million           Q1 2015  Q1 2014  Growth
----------------------------------------------
Core Revenue*           3,563    3,587    (1%)
Core EBIT*                216      729   (70%)
Core EPS*                0.66     2.25   (71%)
Core EBIT margin           6%      20%       -
Reported Revenue        3,563    3,587    (1%)
Reported EBIT            (32)      569       -
Reported EPS           (0.41)     1.69       -
Reported EBIT margin   (0.9%)    15.9%       -

*For definition of the measures 'Core Revenue', 'Core EBIT' and 'Core EPS', see
page 14, and reconciliation to reported figures, see page 21-22
News Source: NASDAQ OMX



---------------------------------------------------------------------

2015-05-06 Dissemination of a Corporate News, transmitted by DGAP - a
service of EQS Group AG.
The issuer is solely responsible for the content of this announcement.

The DGAP Distribution Services include Regulatory Announcements,
Financial/Corporate News and Press Releases.
Media archive at www.dgap-medientreff.de and www.dgap.de

---------------------------------------------------------------------


Language:    English          
Company:     H. Lundbeck A/S  
 
 
             Denmark          
ISIN:        DK0010287234     
 
 
End of News    DGAP News-Service  
---------------------------------------------------------------------  
353497 2015-05-06